Extendicare (EXE) Competitors

Extendicare (TSE:EXE) and dentalcorp (TSE:DNTL) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

Is EXE or DNTL a better dividend stock?

Extendicare pays an annual dividend of C$0.49 per share and has a dividend yield of 3.3%. dentalcorp pays an annual dividend of C$0.05 per share and has a dividend yield of 0.5%. Extendicare pays out 50.6% of its earnings in the form of a dividend. dentalcorp pays out -21.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Do institutionals and insiders hold more shares of EXE or DNTL?

17.7% of Extendicare shares are held by institutional investors. Comparatively, 14.8% of dentalcorp shares are held by institutional investors. 13.9% of Extendicare shares are held by company insiders. Comparatively, 0.2% of dentalcorp shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has preferable earnings & valuation, EXE or DNTL?

Extendicare has higher earnings, but lower revenue than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.51B	0.81	C$65.46M	C$0.97	15.13
dentalcorp	C$1.62B	1.34	-C$80.68M	-C$0.23	-47.35

Does the media favor EXE or DNTL?

In the previous week, Extendicare had 3 more articles in the media than dentalcorp. MarketBeat recorded 3 mentions for Extendicare and 0 mentions for dentalcorp. Extendicare's average media sentiment score of 0.89 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the media.

Company	Overall Sentiment
Extendicare	Positive
dentalcorp	Neutral

Which has more risk and volatility, EXE or DNTL?

Extendicare has a beta of 0.884611, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, dentalcorp has a beta of 1.390366, meaning that its stock price is 39% more volatile than the S&P 500.

Is EXE or DNTL more profitable?

Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	4.48%	64.13%	7.16%
dentalcorp	-5.40%	-4.71%	0.77%

Do analysts rate EXE or DNTL?

Extendicare currently has a consensus price target of C$15.20, suggesting a potential upside of 4.11%. dentalcorp has a consensus price target of C$11.55, suggesting a potential upside of 6.06%. Given dentalcorp's higher probable upside, analysts clearly believe dentalcorp is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.86
dentalcorp	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Summary

Extendicare beats dentalcorp on 13 of the 18 factors compared between the two stocks.